Document is current
Any future updates will be listed below
-
Authors
Ellis, Anne K. https://orcid.org/0000-0002-0725-2353
Hossenbaccus, Lubnaa
Linton, Sophia
Botting, Hannah
Badawod, Eman
Burrows, Alyssa
Garvey, Sarah
-
Funding
Funding for this research was provided by:
Pfizer Canada
- License Information
-
More Information
Article History
Received: 15 January 2024
Accepted: 11 October 2024
First Online: 8 February 2025
Declarations
:
: AKE has participated in advisory boards for ALK Abello, AstraZeneca, Bausch Health, LEO Pharma, Miravo, Merck, Novartis, has been a speaker for ALK Abello, AstraZeneca, Bausch, Miravo, Medexus, Mylan, Novartis, Pfizer, Sanofi, Stallergenes Greer and Regeneron. Her institution has received research grants from ALK Abello, Aralez, AstraZeneca, Bayer LLC, Medexus, Novartis, Sanofi and Regeneron. She has also served as an independent consultant to Bayer LLC, Pharming, and Regeneron. At the time of submission she is the President of the Canadian Society of Allergy and Clinical Immunology (CSACI).
: This study was reviewed and granted ethical clearance by the Queen’s University and Affiliated Teaching Hospitals Health Sciences Human Research Ethics Board. All study participants consented to participate.
: All study participants consented for publication of these study findings.
